维普中文期刊产品整合服务
1311篇 您的检索式:作者名="Ford A"
    题名 作者 年代 出处 被引量
1Non-viral causes of hepatocellular carcinoma显示文摘Hepatocellular carcinoma(HCC) is the most common primary liver malignancy and represents an international public health concern as one of the most deadly cancers worldwide.The main etiology of HCC is chronic infection with hepatitis B and hepatitis C viruses.However,there are other important factors that contribute to the international burden of HCC.Among these are obesity,diabetes,non-alcoholic steatohepatitis and dietary exposures.Emerging evidence suggests that the etiology of many cases of HCC is in fact multifactorial,encompassing infectious etiologies,comorbid conditions and environmental exposures.Clarification of relevant non-viral causes of HCC will aid in preventative efforts to curb the rising incidence of this disease.Wojciech Blonski David S Kotlyar Kimberly A Forde 2010World Journal of Gastroenterology2010,16,29:25
2Colorectal cancer in patients under 50 years of age:A retrospective analysis of two institutions' experience显示文摘AIM:To investigate the epidemiological characteristics of colorectal cancer(CRC)in patients under 50 years of age across two institutions.METHODS:Records of patients under age 50 years of age who had CRC surgery over a 16 year period were assessed at two institutions.The following documents where reviewed:admission notes,operative notes,and discharge summaries.The main study variables included:age,presenting symptoms,family history,tumor location,operation,stage/differentiation of disease,and post operative complications.Stage of disease was classified according to the American Joint Committee on Cancer TNM staging system:tumor depth;node status;and metastases.RESULTS:CRC was found in 180 patients under age50 years(87 females,93 males;mean age 41.4±6.2years).Young patients accounted for 11.2%of cases during a 6 year period for which the full data set wasavailable.Eight percent had a 1stdegree and 12%a 2nd degree family CRC history.Almost all patients(94%)were symptomatic at diagnosis;common symptoms included:bleeding(59%),obstruction(9%),and abdominal/rectal pain(35%).Evaluation was often delayed and bleeding frequently attributed to hemorrhoids.Advanced stage CRC(Stage 3 or 4)was noted in 53%of patients.Most tumors were distal to the splenic flexure(77%)and 39%involved the rectum.Most patients(95%)had segmental resections;6 patients had subtotal/total colectomy.Poorly differentiated tumors were noted in 12%and mucinous lesions in 19%of patients of which most had Stage 3 or 4 disease.Twenty-two patients(13%)developed recurrence and/or progression of disease to date.Three patients(ages 42,42and 49 years)went on to develop metachronous primary colon cancers within 3 to 4 years of their initial resection.CONCLUSION:CRC was common in young patients with no family history.Young patients with symptoms merit a timely evaluation to avoid presentation with late stage CRC.Elizabeth A Myers Daniel L Feingold Kenneth A Forde Tracey Arnell Joon Ho Jang Richard L Whelan 2013World Journal of Gastroenterology2013,19,34:9
3Budd-Chiari syndrome:A single-center experience显示文摘AIM:To investigate challenges,risk factors,prognostic indicators,and treatment outcomes associated with Budd-Chiari syndrome(BCS)at a tertiary care center.METHODS:A retrospective cohort study was conducted at the University of Pennsylvania in patients with a diagnosis of BCS or hepatic vein thrombosis.All patients receiving care at the University of Pennsylvania,and who had at least 2 clinical encounters in the University of Pennsylvania Health system from January1,2008 to September 10,2013 were eligible for study inclusion.Data were extracted from the electronic medical record of each patient,and recorded in a secure Research Electronic Data Capture database.Logistic regression analyses were applied to identify predictors of outcome of liver transplant(LT)or death.RESULTS:Between January 1,2008 and September10,2013,forty-seven patients were identified.Median age was 42.4 years.Thirty-one(66.0%)were women.A majority were Caucasian(68.1%).At diagnosis,43(91.5%)patients had ascites,27(57.4%)patients had a hematologic disorder associated with a hypercoagulable state and 26(55.3%)had cirrhosis.Forty(85.1%)patients were on anticoagulation(AC),30(63.8%)of whom were maintained on warfarin.Two patients(4.3%)underwent thrombolytic therapy.A transjugular intrahepatic portosystemic shunt(TIPS)was placed in21(44.7%)patients,19(90.5%)of whom were also on AC.Twenty-one(44.7%)received AC alone.Over a median of 974 d,8(17.0%)patients received LT,and10(21.3%)died.The median time from listing to death was 26 mo[interquartile range(IQR)=16,65)].TIPS with AC was utilized more frequently in younger patients(P=0.02).Age,cirrhosis and chronic kidney disease(CKD)were significant predictors of LT or death.CONCLUSION:AC alone was employed as frequently as TIPS with AC,though the latter was used more frequently in younger patients with polycythemia vera.There were no significant differences in treatment outcome regardless of the therapeutic intervention employed.Significant predictors of poor prognosis included age,cirrhosis and CKD.Tanya M Pavri Alan Herbst Rajender Reddy Kimberly A Forde 2014World Journal of Gastroenterology2014,20,43:2
4Do statins reduce hepatitis C RNA titers during routine clinical use?显示文摘AIM: To compare hepatitis C virus (HCV) titers in patients with chronic hepatitis C with and without exposure to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins).METHODS: Medical records were reviewed for 6463 patients with documented HCV infection at a single center between March 2004 and September 2006. Patients with confi rmed viremia and meeting inclusion criteria were assigned to one of three groups: Group A (n = 50), dyslipidemic patients with statin usage during HCV RNA polymerase chain reaction (PCR) determination; Group B (n = 49), dyslipidemic patients with prior or future statin usage but not at the time of HCV RNA PCR determination; and Group C (n = 102), patients without statin usage during the study period. The primary analysis explored the effect of statin therapy on HCV viremia. Secondary analyses assessed class effect, dose response, and effect of other lipid-lowering therapies on HCV viral titers.RESULTS: Median HCV RNA titers did not signif icantly differ among the three groups (Group A: 4 550 000 IU/mL, Group B: 2 850 000 IU/mL, Group C: 3 055 000 IU/mL).For those subjects with longitudinal assessment of HCV viremia prior to and while on statins, there were no signif icant differences between pre- and post-HCV viral titers. Additionally, no differences in HCV titers were observed at any dose level of the most prescribed statin, simvastatin. However, hypertriglyceridemia independently correlated with HCV titers, and niacin exposure was associated with signif icantly lower viral titers (P < 0.05).CONCLUSION: There was no apparent effect of statins on HCV viral replication in this analysis. Further investigation is warranted to explore the possible antiviral properties of triglyceride-lowering agents and their potential role as adjuncts to standard HCV therapy.Kimberly A Forde Connie Law Rose O’Flynn David E Kaplan 2009World Journal of Gastroenterology2009,15,40:2
5Theory and Performance of Narrow Correlator Spacing in a GPS Receiver显示文摘Van Dierendonck A J Fenton P Ford T 1992Navigation1992,39,3:1
6Clinical application of the P3 component of event-related potentials 显示文摘Pfefferbraum A Wenegrat BG Ford JM 1984Electroencephalogr Clin Neurophysiol1984,59,:1
7Psychological correlates of flow in sport显示文摘Jackson S A Kiniecik j C Ford S 1998Journal of Sport and Exercise Psychology1998,20,3:1
8Cosmic strings and black holes显示文摘Aryal M Ford L Vilenkin A 1986Phys Rev1986,34,:1
9GRAS Substances显示文摘Bernard L Oser R A Ford 1998Food Technology1998,52,9:1
10Genetic improvement in the yield of winter:afurther evaluation 显示文摘AUSTIN R B FORD M A MORGAN C L 1989J Agric Sci1989,112,:1
11The role of the surgeon in the evolution of flexible endoscopy显示文摘Morgenthal C B Richards W O Dunkin B J Forde K A Vitale G Lin E 2007Surg Endosc2007,21,6:1
12Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans 显示文摘Castillo U F Strobel G A Ford E J 2002Microbiology2002,148,9:1
13Munumbicins, wide spectrum antibiotics produced by Streptomyces endophytic on Kennedia nigriscans显示文摘CASTILLO U F STROBEL G A FORD E J 2002Microbiology2002,148,:1
14Neonicotinoid insecticides induce salicylate-associated plant defense responses 显示文摘FORD K A CASIDA J E CI-{ANDRAN D 2010PNAS2010,107,17:1
15Evaluation of the oral subchronic tox-icity of HHCB(1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-g-2-benzopyran)in the rat显示文摘Api A M Ford R A 1999Toxi-cology Letters1999,111,12:1
16A long-wavelength fluorescent chemodosimeter selective for Cu(Ⅱ)ion in water显示文摘Dujols V Ford F Czarnik A W 1997Journal of the American Chemical Society1997,119,31:1
17Acin: a 1, 3-di- hydroisobenzofuran from Pestalotiopsis microspora possessing an- tioxidant and antimycotic activities显示文摘Harper J K Ford E J Strobe1 G A 2003Tetrahedron2003,59,:1
18Neural processes associated with antisaccade task performance investigated with event- related fMRI显示文摘FORD K A GOLTZ H C BROWN M R G 2005Journal of Neurophysiology2005,94,1:1
19Estimation,variation and importance of leaf curvature in Zea mays hybrids显示文摘Ford ED Cocke A Horton L Fellner M 2008Agr Forest Meteorol2008,148,:1
20Assessing variation in the radial profile of sap flux density in Pinus species and its effect on daily water use显示文摘Ford C Mcguire M A Mitchell R J 2004Tree Physiology2004,24,3:1
返回顶部 每页显示:
共66页 首页 上一页 第1页 下一页 末页 /66 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费